Authors
Loading...
Randomized trial develops high-activity, low-cost hydrogen evolution catalysts, suggesting an alternative to noble metals.
Zuo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: